Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Insulin Resistance × Tirzepatide × Other × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Gynecologic 1

Conditions

Obesity 8 Endometrial Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Overweight 1 Metabolic Syndrome 1 Insulin Resistance 1 Inflammation 1 Hyperplasia 1 Endometrial Hyperplasia 1 Dyslipidemias 1 Diabetes Mellitus 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Metformin 2 lime 1 licogliflozin 1 Tirzepatide 1 Surveys and Questionnaires 1 Liraglutide 1 Exercise 1 Electroacupuncture 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07065552 2026-01-28

Tirzepatide in Obesity-Driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Not yet recruiting

GynecologicOther

Insulin Resistance, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡